BUY MBP MENINGOCOCCAL VACCINE MENACTRA 0.5ML VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Menactra 0.5 mL is a vaccine used to protect against meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. Meningococcal disease is a serious and potentially life-threatening infection that can cause meningitis, which is inflammation of the lining of the brain and spinal cord, or septicaemia, a severe blood infection. These conditions can progress very rapidly and may lead to long-term disability or death if not prevented or treated early.

Menactra works by stimulating the immune system to produce protective antibodies against the four major meningococcal bacteria included in the vaccine. It does not contain live bacteria, so it cannot cause meningococcal disease. Instead, it trains the immune system to recognise and fight the bacteria if the person is exposed in the future.

Menactra is given as a single 0.5 mL injection into a muscle, usually in the upper arm for older children, adolescents, and adults, or in the thigh for younger children. It is commonly given as part of routine immunisation schedules for infants, children, adolescents, and people at increased risk of meningococcal disease. This includes travellers to certain countries, people living in close or crowded environments, individuals with weakened immune systems, and those with certain medical conditions such as absence of a functioning spleen.

After receiving Menactra, the body begins to develop immunity within a few weeks. Protection is long lasting, but booster doses may be required in some people depending on age, risk level, or ongoing exposure to meningococcal disease. Your healthcare provider will advise if and when a booster is needed.

Common side effects of Menactra are usually mild and short-lived. These may include pain, redness, or swelling at the injection site, mild fever, headache, tiredness, muscle aches, or irritability. These symptoms typically resolve within a few days and are a normal sign that the immune system is responding to the vaccine.

Some people may experience mild nausea, loss of appetite, or drowsiness after vaccination. In children, temporary fussiness or reduced appetite may occur. Serious side effects are very rare, but allergic reactions can happen. Signs of a severe allergic reaction include difficulty breathing, swelling of the face or throat, hives, or sudden weakness. If these occur, urgent medical attention is required.

Menactra should not be given to anyone who has had a severe allergic reaction to a previous dose of the vaccine or to any of its components. It may be postponed in people who are acutely unwell with a moderate or severe illness, although mild illnesses such as a cold are usually not a reason to delay vaccination.

Menactra can be safely given alongside many other vaccines during the same visit, using different injection sites. This helps ensure timely protection without unnecessary delays.

Vaccination with Menactra is an important step in preventing meningococcal disease, which can develop suddenly and progress rapidly. Even with treatment, meningococcal infections can cause serious complications such as hearing loss, brain damage, limb loss, or death. Vaccination significantly reduces these risks and helps protect both individuals and the wider community.

Overall, Menactra is a safe, effective, and well-tolerated vaccine that plays a vital role in protecting against severe and potentially life-threatening meningococcal infections.